Article
Prognostic impact of myelodysplasia-related gene mutations in ELN-2022 favorable-risk acute myeloid leukemia subtypes.
Annals of medicine - 1 Dec 2026
Zhang Lulu, Ying Shuangwei, Fang Fang, Li Qian, An Furun, Li Jingwen, Sun Jie, Zheng Weiyan, Zhai Zhimin, Zhu Yuanyuan
Abstract excerpt
BACKGROUND: The 2022 European Leukemia Net (ELN) risk stratification categorizes acute myeloid leukemia (AML) with myelodysplasia-related gene (MRG) mutations - including ASXL1, BCOR, EZH2, RUNX1, SF3B1, SRSF2, STAG2, U2AF1 and/or ZRSR2 - as "adverse-risk". However, the prognostic relevance of MRG mutations in patients with favorable-risk AML remains uncertain. METHODS: In this study, we analyzed a cohort of 221...
Topics
Join the communities discussing this publication.
